
Worker Protection from Heat Stress: Now More Than Ever, It's Up to Employers to Do The Right Thing
'The reality is, a federally mandated heat stress standard in the U.S. may not happen anytime soon,' says Greg Schrab, President at Ergodyne, a leader in safety work gear and heat stress prevention. 'But regulation should never be the reason we protect workers. Employers don't need a federal rule to tell them that heat stress is dangerous, or that simple, proven solutions can save lives.'
With extreme heat becoming a predictable threat year after year, safety professionals are stepping up where federal regulations fall short—turning to resources like OSHA's NEP, ANSI/ASSP A10.50-2024, state regulations, and industry safety leaders to build and reinforce heat stress prevention programs that work.
From implementing hydration and rest schedules to providing personal cooling gear, the industry's best practices are well-documented. The challenge for many employers isn't knowing what to do—it's making sure it gets done.
Randy Milliron, Safety Manager for the City of Gillette, Wyoming, agrees. He points to time-tested basics as the foundation of his program. 'It will sound so rudimentary, but if you keep to the classics you can safely work outside when the thermostat starts to rise. Drinking plenty of fluids, monitoring urine output and color, taking breaks in the shade, and looking out for your co-workers are the key things to help you stay cool and hydrated.'
To help worksites put prevention into practice, Ergodyne is expanding its cooling gear and heat stress solutions with new advancements in wearable cooling, flame-resistant cooling PPE, and turnkey heat stress prevention kits. But gear is only part of the equation. The St. Paul, MN-based worksite safety leader and cooling category pioneer is in the field working alongside employers to provide on-site education in support of company heat stress prevention programs.
'Unless you are attending safety conferences and rubbing elbows with the vendors who provide this type of PPE, you might not know of all the advancements that have been made in these product lines,' Milliron says. 'So, I believe it is necessary, if you are a safety professional, to find those subject-matter experts who specialize in cooling products and create long-lasting friendships with them.'
Milliron has seen firsthand how proactive prevention can make a difference. 'Last summer we had a seasonal employee try to work through the early signs and symptoms of heat illness. By the time I arrived, he was in bad shape. We moved him into the air-conditioned office and applied ice packs and a cooling towel to his groin and neck. It took a very long time for his symptoms to subside, but the cooling towel did the trick at lowering his core body temperature.'
By leveraging proven cooling solutions and industry-backed guidance, safety leaders can make sure their teams stay safe, stay productive, and stay protected—regardless of what happens at the federal level.
'In the absence of federal action, it's up to employers to step up,' says Lexi Engelbart, Product Manager at Ergodyne and Vice Chair of the International Safety Equipment Association's (ISEA) Heat Stress Solutions Group. 'Not because they have to, but because it's the right thing to do.'
For more heat stress education, including signs, symptoms, and solutions, visit ergodyne.com/heat-stress.
ABOUT ERGODYNE
Since 1983, Tenacious Holdings, Inc. (dba Ergodyne, a Klein Tools Company) has pioneered the development of products that Make The Workplace A Betterplace™. What started with just one product has grown into a line of top flight, battle-tested, Tenacious Work Gear®; all precision crafted to provide protection, promote prevention and manage the elements for workers on jobsites the world over. The current lineup is extensive and constantly growing: ProFlex® Hand Protection, ProFlex® Knee Pads, ProFlex® Supports, Skullerz® Head & Face Protection, Skullerz® Eye Protection, Trex® Traction, KREW'D® Skin Protection, Chill-Its® Cooling Products, N-Ferno® Warming Products, GloWear® Hi-Vis Apparel, Squids® Lanyards, Arsenal® Gear and Tool Storage, and SHAX® Portable Work Shelters.
Originally posted on: www.ergodyne.com
Attachment New Heat Stress Hazard Solutions
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.
Ahmedabad Plane Crash
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
.jpeg&w=3840&q=100)

Miami Herald
an hour ago
- Miami Herald
Red panda known for ‘playful sass' dies, Utah zoo says. She was a guest favorite
An 8-year-old red panda known for her 'playful sass' and 'calm confidence' died after a severe health decline, Utah zookeepers said. Kiaria, a Chinese red panda, came to the Hogle Zoo in November as part of a breeding program by the Association of Zoos and Aquariums' Red Panda Species Survival Plan (SSP), according to an Aug. 18 news release by the Salt Lake City-based zoo. Kiaria had a history of gastrointestinal issues, which are common for red pandas, under human care, but in the recent months, she 'had been eating well, sleeping, and showing her playful personality,' the zoo said. On Aug. 14, her health began to rapidly decline, and after trying various treatments, the veterinary staff determined she would not recover, so she was humanely euthanized, zookeepers said. Gastrointestinal issues are the third-leading cause of death in Chinese red pandas living in North American zoos, SSP Red Panda co-vet advisor James Steeil said in the release. The 'confident' Kiaria, known as the 'boss of the cool room,' became a guest favorite after being debuted in March, the zoo said. She would spend time with William, a 2-year-old Chinese red panda, as part of the breeding program but preferred her own space as red pandas are 'naturally solitary,' the zoo said. Chinese red pandas have reddish coats and stripes on their tails with 'larger bodies and longer fur to help retain warmth,' zookeepers said. The species faces threats of habitat loss and poaching, causing a 40% decline in overall population of Chinese red pandasin the last 20 years, the zoo said. 'It was an immense privilege to have Kiaria in our care. She was a meaningful ambassador for her endangered species, helping to inspire greater understanding and appreciation for red pandas,' zookeepers said.
Yahoo
2 hours ago
- Yahoo
Larkspur Biosciences Announces Discovery of LRK-4189, a First-in-Class Degrader of the Lipid Kinase PIP4K2C, for the Treatment of Microsatellite Stable (MSS) Colorectal Cancer at the ACS Fall 2025 Meeting
First-in-human, Phase 1 Study of LRK-4189 to Begin in the Fourth Quarter CAMBRIDGE, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Larkspur Biosciences, a company pioneering a new wave in cancer therapy that destroys tumors by targeting cancer cell fitness, today announced the discovery of LRK-4189, a first-in-class degrader of the lipid kinase PIP4K2C for the treatment of microsatellite stable (MSS) colorectal cancer (CRC) and other solid tumors. The announcement was made at a presentation Larkspur was invited to give at the prestigious MEDI First Time Disclosures: Breakthroughs on New Medicines session at ACS Fall 2025, a meeting of the American Chemical Society in Washington, DC. Cancer cells maintain their fitness by developing survival adaptations that foster escape from intrinsic and extrinsic mechanisms of cell death in conditions of stress. Phosphatidylinositol 5-phosphate 4-kinase, type II, gamma (PIP4K2C) is a lipid kinase associated with poor outcomes in a range of cancers including CRC and breast cancers. PIP4K2C is co-opted by cancer cells to increase their fitness by evading immune surveillance and adapting to stress. 'Genetic studies have long highlighted PIP4K2C as a key player in cancer stress adaptation, but its extremely low kinase activity made it resistant to conventional inhibition approaches,' said Catherine Sabatos-Peyton, PhD, CEO of Larkspur Biosciences. 'With our novel degrader, LRK-4189, we've finally unlocked this critical pathway. By reducing cancer cell fitness, triggering intrinsic apoptosis, and engaging the immune system to clear residual tumor cells, LRK-4189 has the potential to overcome the limitations of earlier therapies. We're excited to advance this promising therapy to the clinic later this year.' According to the American Cancer Society, in the United States, approximately 150,000 cases of CRC are diagnosed annually, with MSS CRC accounting for about 85% of all CRC cases. About LRK-4189 LRK-4189 is an orally bioavailable, selective degrader of PIP4K2C with subnanomolar potency in primary human cells. LRK-4189-mediated degradation of PIP4K2C leads to intrinsic cancer cell death and activates interferon signaling, triggering multiple killing mechanisms in difficult-to-treat MSS CRC cells. In vivo, LRK-4189 demonstrates dose dependent PKPD with single agent efficacy in multiple models of CRC and synergy with first-line standard of care chemotherapy. In primary human CRC patient-derived spheroids, 50% of patient samples respond to LRK-4189 with a preferential response in MSS CRC, which compares favorably to benchmark cetuximab in the same platform (35%). Cetuximab may be either a first- or second-line treatment in people with RAS wild type CRC. LRK-4189 has completed IND-enabling studies and expects to initiate a Phase 1 clinical trial in Q4 2025. About Larkspur Biosciences Larkspur Biosciences is pioneering a new wave in cancer therapy that destroys tumors by targeting cancer cell fitness. Larkspur develops therapies that decrease cancer cell fitness and sensitizes the cells to intrinsic and immune-driven mechanisms of killing. The company is advancing first-in-class programs that target the adaptations cancer cells use to proliferate, invade tissue, and escape the immune system. LarkX, the company's proprietary bioinformatics platform, couples machine learning with tumor genetics to discover cancer cell fitness pathways that originate in the tumor and enrich clinical strategies for potential responders to its therapies across multiple types of cancer. Larkspur's founders include Lewis C. Cantley, PhD, professor of medicine at Dana-Farber Cancer Institute, professor of cell biology at Harvard Medical School; Vijay K. Kuchroo, DVM, PhD, professor of neurology at Harvard Medical School, senior scientist at Brigham and Women's Hospital; and Nathanael Gray, PhD, professor of chemical and systems biology at Stanford University. Visit us at and follow us on LinkedIn and X. Media Contact:Dan BoyleScientPRdan@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Dr. Ritesh Kalra Scholarship to Support Aspiring Medical Professionals
Dr. Ritesh Kalra Scholarship SECAUCUS, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- The Dr. Ritesh Kalra Scholarship for Medical Students is now accepting applications for its 2026 award cycle, offering a $1,000 prize to a deserving undergraduate student on the path to becoming a doctor. Established by acclaimed physician Dr. Ritesh Kalra, this initiative seeks to encourage academic excellence, foster a spirit of compassion in medicine, and provide financial assistance to future healthcare leaders. The scholarship will be awarded through an engaging essay contest, providing applicants with an opportunity to share their vision for the future of medicine. Students are invited to reflect on the balance between technological advancements in healthcare and the human connection that remains at the heart of patient care. The award is open to undergraduate students in accredited institutions who are committed to pursuing a medical career. 'This scholarship represents more than financial assistance—it's a way to inspire the next generation of physicians to uphold both innovation and empathy in their work,' said Dr. Kalra. 'Medicine is not only a science; it's a calling that requires skill, dedication, and a genuine desire to help others.' About Dr. Ritesh Kalra Dr. Ritesh Kalra is a highly respected internal medicine specialist with decades of service in both private practice and hospital settings. His career spans extensive clinical work, award-winning research, and mentorship of medical students. Trained across prestigious institutions in Poland, New York, and Georgia, Dr. Ritesh Kalra has earned repeated recognition as a Top Doctor in Internal Medicine from 2020 through 2025. Fluent in Hindi and Punjabi, he connects with a diverse patient population and has devoted his career to improving healthcare delivery and patient outcomes. His inspiration for creating the scholarship stems from his belief in the power of education and the critical role that young, motivated doctors will play in the future of global health. Application Details The Dr. Ritesh Kalra Scholarship for Medical Students is open to all undergraduate students enrolled in accredited U.S. institutions who are on an academic track toward becoming a physician. Applicants must submit a 750–1,000-word original essay responding to the following prompt: "In the rapidly evolving field of medicine, how can future doctors balance technological advancement with the human connection that lies at the heart of patient care? Share your thoughts, supported by personal experiences, observations, or aspirations." Submissions should demonstrate critical thinking, originality, and a strong personal commitment to the medical field. Important Dates Application Deadline: May 15, 2026 Winner Announcement: June 15, 2026 The winning essay will be selected by the scholarship review committee based on insight, clarity, creativity, and the ability to convey a compelling vision for the future of healthcare. The $1,000 award will be sent directly to the recipient to support their educational expenses. How to Apply Applicants should send their essay along with their full name, contact information, school name, and field of study to apply@ The subject line should read: Dr. Ritesh Kalra Scholarship Application. The scholarship reflects Dr. Ritesh Kalra's ongoing mission to support the academic journeys of aspiring doctors and to encourage them to integrate technological expertise with compassionate care. Through this program, he hopes to inspire students to pursue medicine not only as a career but as a lifelong service to humanity. Contact InformationSpokesperson: Dr. Ritesh KalraOrganization: Dr. Ritesh Kalra Scholarship for Medical StudentsWebsite: apply@ A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data